MB

MPM BioImpact Portfolio holdings

AUM $611M
1-Year Est. Return 29.61%
This Quarter Est. Return
1 Year Est. Return
+29.61%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$497M
AUM Growth
+$112M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$31M
2
+$15.1M
3
+$11.6M
4
XERS icon
Xeris Biopharma Holdings
XERS
+$10.4M
5
KALV icon
KalVista Pharmaceuticals
KALV
+$6.85M

Top Sells

1
+$28.3M
2
+$22.5M
3
+$7.01M
4
TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
+$5.06M
5
ARQT icon
Arcutis Biotherapeutics
ARQT
+$2.8M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$6.07M 1.22%
+255,323
27
$5.52M 1.11%
+712,798
28
$4.71M 0.95%
+5,095,912
29
$4.18M 0.84%
+462,500
30
$4.04M 0.81%
282,332
+69,717
31
$2.27M 0.46%
319,671
32
$1.82M 0.37%
326,921
+93,193
33
$1.04M 0.21%
+31,747
34
$96.3K 0.02%
2,377,031
35
– –
-254,137
36
– –
-144,888
37
– –
-348,224
38
– –
-53,993
39
– –
-3,370,982
40
– –
-1,173,809
41
– –
-1,192,281
1
2